Skip to content

Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia

Impact of 80 Watt KTP Photoselective Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia: 6-Month Results of a Nonrandomized Prospective Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00908427
Enrollment
86
Registered
2009-05-25
Start date
2004-06-30
Completion date
2007-09-30
Last updated
2009-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia

Keywords

benign prostatic hyperplasia, KTP laser, transurethral resection of prostate, urinary bladder neck obstruction

Brief summary

The purpose of this study is to compared the efficacy of 80W KTP photoselective laser vaporization prostatectomy (PVP) and transurethral resection of the prostate (TURP) in reducing the volume of prostate and relieving the obstruction in men with benign prostatic hyperplasia (BPH) on non-randomized controlled design.

Interventions

PROCEDUREphotoselective vaporization prostatectomy (PVP)

PVP using 80 W KTP laser with a Greenlight system (GreenLight PVTM, Laserscope®, San Jose, CA)

Standard transurethral resection of the prostate using electrocautery loop

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Symptomatic BPH * International Score Prostate Symptom (IPSS) of 13 or greater * prostate volume of 30 to 100 ML * Peak urinary flow rate (Qmax) less than 15 mL/s with a voided volume of \>125 mL and a PVR \<350mL * Able to give fully informed consent

Exclusion criteria

* Subjects with histological diagnosis of prostate cancer * Subjects with history of chronic urinary retention * Subjects with urethral stricture, * Subjects with bladder neck contracture * Subjects with urinary tract infection * Subjects with prostate volume on TRUS of \>100 mL * Subjects with suspected neurogenic bladder dysfunction * Subjects who, in the opinion of investigator, are not likely to complete the study for whatever reason

Design outcomes

Primary

MeasureTime frame
The changes of bladder outlet obstruction index (BOOI)6months

Secondary

MeasureTime frame
The changes of Uroflowmetry (UFM) and Postvoid residual urine(PVR)6, 12 months
The changes of detrusor pressure at maximum flow rate (PdetQmax)parameters6months
The changes of International Prostatic Symptom Scores (IPSS)6, 12 months
The changes of Schafer obstruction grade parameters6months
The changes of Quality of Life (QoL) parameters6, 12 months
postoperative catheterization daysimmediate postoperative period
ComplicationsDuring all study periods
The changes of the hemoglobin and the serum sodium and the serum PSAimmediate postoperative period
The change of IIEF score6, 12 months
The changes of prostate volume6, 12 months

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026